LexaGene in New York Times

LexaGene mentioned in New York Times article focusing on genomic testing efforts to combat COVID-19. The LX Analyzer will be a game-changing way to run these tests quickly and cost-effectively to diagnose disease and to detect novel pathogens. > Read now.